Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 10-60 years 2. Sex : Both genders 3. Patients of striae distensae 4. Parents/ guardian giving written informed consent will be taken
Exclusion criteria
Exclusion criteria: 1. Pregnancy or lactation 2. History of dermatological conditions (e.g., active infections, autoimmune diseases) 3. Hypertrophic or keloid scarring tendencies 4. People with unrealistic expectations 5. Pacemaker implantation 6. Active cancer, bleeding disorders, or other severe comorbidities 7. Parents/ guardian not giving written informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical outcome assessed through Manchester Scoring System at baseline, 4 weeks , 8 weeks , and 12 weeks post-treatment. Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Satisfaction: To assess the overall improvement in appearance and quality of life. Side Effects: Any adverse events such as erythema, edema, pigmentation changes, or scarring will be recorded.Timepoint: 3 months | — |
Countries
India
Contacts
Muzaffarnagar medical college and hospital